Gaudium IVF

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0P8B01020
  • NSEID: GAUDIUMIVF
  • BSEID: 544709
INR
105.75
0.00 (0.00%)
BSENSE

Jun 09, 03:30 PM

BSE+NSE Vol: 2.43 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.43 lacs (504.45%) Volume

Shareholding (Mar 2026)

FII

6.70%

Held by 6 FIIs

DII

2.63%

Held by 2 DIIs

Promoter

71.29%

Why is Gaudium IVF and Women Health Ltd falling/rising?

10-Jun-2026

As of 09-Jun, Gaudium IVF and Women Health Ltd's stock price is rising to 105.30, marking a trend reversal after nine days of decline and outperforming its sector. Increased investor participation and favorable moving average positioning suggest a shift in market sentiment towards the stock.

As of 09-Jun, Gaudium IVF and Women Health Ltd's stock price is rising, currently at 105.30, which reflects an increase of 2.05 or 1.99%. This upward movement is notable as it marks a trend reversal after nine consecutive days of decline. Additionally, the stock has outperformed its sector by 0.74% today, indicating a relative strength compared to its peers.<BR><BR>Investor participation appears to be increasing, with a delivery volume of 29.54k on June 8, which is up by 4.2% compared to the five-day average. This suggests growing interest among investors, contributing to the stock's upward momentum. Furthermore, the stock is currently trading above the 50-day, 100-day, and 200-day moving averages, although it remains below the 5-day and 20-day moving averages. This positioning indicates a potential shift in market sentiment towards the stock.<BR><BR>Overall, the combination of a trend reversal, increased investor participation, and relative outperformance in the sector are key factors contributing to the rise in Gaudium IVF and Women Health Ltd's stock price.

View full answer

Should I buy, sell or hold Gaudium IVF and Women Health Ltd?

09-Jun-2026
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Flat results in Mar 26

 
2

With ROCE of 20.9, it has a Expensive valuation with a 4.7 Enterprise value to Capital Employed

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR Cr (Micro Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
30 Cr
(Quarterly Results - Mar 2026)
Net Profit:
8 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
36.88%
0%
36.88%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Gaudium IVF for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
14.59
Debt to EBITDA (avg)
0.65
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.59
Tax Ratio
23.94%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
9.32%
ROCE (avg)
20.92%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
28
Industry P/E
60
Price to Book Value
5.03
EV to EBIT
22.25
EV to EBITDA
20.74
EV to Capital Employed
4.65
EV to Sales
7.50
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
20.92%
ROE (Latest)
16.08%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
KST
Dow Theory
Mildly Bearish
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 6 FIIs (6.7%)

Promoter with highest holding

Manika Khanna (70.73%)

Highest Public shareholder

Mukul Mahavir Agrawal (3.43%)

Individual Investors Holdings

14.67%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 56.24% vs -38.17% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 143.08% vs -64.78% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22.17",
          "val2": "14.19",
          "chgp": "56.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.27",
          "val2": "5.83",
          "chgp": "93.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.24",
          "val2": "1.12",
          "chgp": "10.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "7.73",
          "val2": "3.18",
          "chgp": "143.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "50.83%",
          "val2": "41.09%",
          "chgp": "9.74%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Gaudium IVF"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Gaudium IVF"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 21.32% vs 12.98% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 19.65% vs 11.96% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "71.58",
          "val2": "59.00",
          "chgp": "21.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "34.57",
          "val2": "27.86",
          "chgp": "24.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.36",
          "val2": "1.39",
          "chgp": "141.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "22.29",
          "val2": "18.63",
          "chgp": "19.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "48.30%",
          "val2": "47.22%",
          "chgp": "1.08%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
22.17
14.19
56.24%
Operating Profit (PBDIT) excl Other Income
11.27
5.83
93.31%
Interest
1.24
1.12
10.71%
Exceptional Items
0.00
0.00
Standalone Net Profit
7.73
3.18
143.08%
Operating Profit Margin (Excl OI)
50.83%
41.09%
9.74%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 56.24% vs -38.17% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 143.08% vs -64.78% in Dec 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
71.58
59.00
21.32%
Operating Profit (PBDIT) excl Other Income
34.57
27.86
24.08%
Interest
3.36
1.39
141.73%
Exceptional Items
0.00
0.00
Standalone Net Profit
22.29
18.63
19.65%
Operating Profit Margin (Excl OI)
48.30%
47.22%
1.08%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 21.32% vs 12.98% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 19.65% vs 11.96% in Mar 2025

stock-summaryCompany CV
About Gaudium IVF and Women Health Ltd stock-summary
stock-summary
Gaudium IVF and Women Health Ltd
Micro Cap
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available